China No. 2 Pharma Swallows Beijing Pharma's Four Subsidiaries For RMB 404 Million
This article was originally published in PharmAsia News
Executive Summary
China Resources Sanjiu Medical & Pharmaceutical Co. Ltd. yesterday declared its plans to buy four Beijing Pharmaceutical Group Co. Ltd. subsidiaries for RMB 404 million which is 19.8 times the firms' 2010 P/E ratios